A Diagnostic Marker for Matrix Metalloprotease (MMP)-2 and -9 Activity in Cancer Tissue
This invention is a new and simple method for the identification of active versus latent matrix metalloprotease enzymes (MMPs) in tissue.
Technology Summary
MMPs are involved in tumor progression and therefore are targets for anti-cancer drug therapies. However, most drug therapies directed at inhibition of MMPs have failed because there is no reliable...
Published: 9/26/2025
|
Inventor(s): Avraham Raz, Rafael Fridman, Pratima Nangia-Makker
Keywords(s): Biomarker, Cancer, Driving Lifelong Health, Enzyme, Method
Category(s): Technology Category > Therapeutics, Technology Category > Research tools, Technology Category > Oncology, Technology Category > Life Science, Technology Category > Diseases, Technology Category > Research tools > Antibodies
|